United States Biotechnology & Medical Research

Nektar Therapeutics (NKTR)

Track

Track

Nektar Therapeutics recorded fifteen insider trading transactions over the past ninety days, totaling approximately 4.32 million dollars in sales. Key executives, including the CEO and R&D head, executed these divestments following a positive earnings report. The stock price has appreciated 34.9 percent during this period, reflecting significant market activity.
Ticker: NKTR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nektar Therapeutics. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
310.97
Quantity 44,827 -13.7%
Value US$224,993
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
455.64
Quantity 6,564 -0.6%
Value US$3,454,797
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
498.65
Quantity 55,493
Value US$322,164
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
71.98
Quantity 418
Value US$30,087
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
70.00
Quantity 5,681 -36.8%
Value US$397,670
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
65.39
Quantity 5,681
Value US$371,481
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
65.39
Quantity 5,681
Value US$371,481
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
61.65
Quantity 4,500 -7.6%
Value US$277,425
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
60.81
Quantity 5,500 -8.5%
Value US$334,455
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
60.27
Quantity 10,000
Value US$602,700
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
60.71
Quantity 4,697 -6.7%
Value US$285,155
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
59.97
Quantity 5,303 -7.1%
Value US$318,021
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
60.96
Quantity 10,000
Value US$609,600
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
60.71
Quantity 5,538 -26.4%
Value US$336,212
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
59.38
Quantity 5,538
Value US$328,846
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
65.51
Quantity 444 -0.6%
Value US$29,086
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
65.51
Quantity 199 -0.9%
Value US$13,036
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
65.51
Quantity 199
Value US$13,036
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
65.51
Quantity 444
Value US$29,085
4.0
Wilson Mark Andrew Former Officer Officer
Transaction date
Proposed sale
Price
72.64
Quantity 78,510
Value US$5,702,966
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
73.00
Quantity 180 -0.8%
Value US$13,140
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
73.00
Quantity 423 -0.6%
Value US$30,879
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
73.00
Quantity 423
Value US$30,878
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
73.00
Quantity 180
Value US$13,140
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
35.67
Quantity 3,867 -15.3%
Value US$137,936
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
35.67
Quantity 3,867
Value US$137,946
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
58.82
Quantity 2,207
Value US$129,812
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
58.82
Quantity 630
Value US$37,056
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
58.82
Quantity 1,157
Value US$68,053
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
54.28
Quantity 630 -2.8%
Value US$34,196
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
54.28
Quantity 2,207 -3.9%
Value US$119,796
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
54.28
Quantity 1,157 -5.7%
Value US$62,802
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
48.18
Quantity 1,210 -2.4%
Value US$58,298
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
47.49
Quantity 2,156 -4.1%
Value US$102,388
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
46.41
Quantity 1,200 -2.2%
Value US$55,692
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
45.16
Quantity 2,100 -3.7%
Value US$94,836
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
46.69
Quantity 6,666
Value US$311,205
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
39.89
Quantity 1,136 -2.0%
Value US$45,315
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
38.82
Quantity 2,226 -3.7%
Value US$86,413
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
37.87
Quantity 3,304 -5.3%
Value US$125,122
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
38.53
Quantity 6,666
Value US$256,838
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
35.80
Quantity 1,134 -1.8%
Value US$40,597
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
34.40
Quantity 613 -1.0%
Value US$21,087
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
33.54
Quantity 1,496 -2.3%
Value US$50,176
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
32.37
Quantity 1,923 -2.8%
Value US$62,248
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
35.69
Quantity 307 -1.7%
Value US$10,957
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
34.41
Quantity 189 -1.1%
Value US$6,503
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
33.60
Quantity 432 -2.3%
Value US$14,515
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
32.43
Quantity 793 -4.1%
Value US$25,717
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
33.70
Quantity 5,166
Value US$174,119
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
33.52
Quantity 1,721
Value US$57,688
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
30.16
Quantity 1,500 -2.2%
Value US$45,240
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
30.10
Quantity 485 -2.5%
Value US$14,598
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
30.10
Quantity 485
Value US$14,600
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.16
Quantity 1,500
Value US$45,244
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
26.59
Quantity 725 -3.6%
Value US$19,278
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
26.59
Quantity 676 -3.2%
Value US$17,975
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
26.59
Quantity 1,573 -2.2%
Value US$41,826
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
26.59
Quantity 1,573
Value US$41,826
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
26.59
Quantity 676
Value US$17,975
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
26.59
Quantity 725
Value US$19,278
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
0.67
Quantity 10,712 -3.4%
Value US$7,177
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
0.67
Quantity 23,208 -2.1%
Value US$15,549
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
0.67
Quantity 9,996 -3.1%
Value US$6,697
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
0.67
Quantity 10,712
Value US$7,191
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
0.67
Quantity 9,996
Value US$6,710
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.67
Quantity 23,208
Value US$15,580
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
1.01
Quantity 11,040 -3.3%
Value US$11,150
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
1.01
Quantity 10,300 -3.2%
Value US$10,403
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
1.01
Quantity 23,774 -2.1%
Value US$24,012
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
1.01
Quantity 11,040
Value US$11,137
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.01
Quantity 23,774
Value US$23,983
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
1.01
Quantity 10,300
Value US$10,391
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
0.89
Quantity 16,560
Value US$14,801
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
0.89
Quantity 16,560 -4.7%
Value US$14,738
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-18 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
44,827 -13.7%
310.97
US$224,993 		44,827 -13.7% 310.97 US$224,993
2026-08-20 2026-08-18 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
6,564 -0.6%
455.64
US$3,454,797 		6,564 -0.6% 455.64 US$3,454,797
2026-08-18 2026-08-18 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
55,493
498.65
US$322,164 		55,493 498.65 US$322,164
2026-08-18 2026-08-18 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
418
71.98
US$30,087 		418 71.98 US$30,087
2026-07-02 2026-06-30 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
5,681 -36.8%
70.00
US$397,670 		5,681 -36.8% 70.00 US$397,670
2026-06-30 2026-06-30 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,681
65.39
US$371,481 		5,681 65.39 US$371,481
2026-06-30 2026-06-30 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,681
65.39
US$371,481 		5,681 65.39 US$371,481
2026-06-18 2026-06-17 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
4,500 -7.6%
61.65
US$277,425 		4,500 -7.6% 61.65 US$277,425
2026-06-18 2026-06-17 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
5,500 -8.5%
60.81
US$334,455 		5,500 -8.5% 60.81 US$334,455
2026-06-17 2026-06-17 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
10,000
60.27
US$602,700 		10,000 60.27 US$602,700
2026-06-18 2026-06-16 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
4,697 -6.7%
60.71
US$285,155 		4,697 -6.7% 60.71 US$285,155
2026-06-18 2026-06-16 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
5,303 -7.1%
59.97
US$318,021 		5,303 -7.1% 59.97 US$318,021
2026-06-16 2026-06-16 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
10,000
60.96
US$609,600 		10,000 60.96 US$609,600
2026-06-17 2026-06-15 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
5,538 -26.4%
60.71
US$336,212 		5,538 -26.4% 60.71 US$336,212
2026-06-15 2026-06-15 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,538
59.38
US$328,846 		5,538 59.38 US$328,846
2026-05-21 2026-05-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
444 -0.6%
65.51
US$29,086 		444 -0.6% 65.51 US$29,086
2026-05-21 2026-05-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
199 -0.9%
65.51
US$13,036 		199 -0.9% 65.51 US$13,036
2026-05-19 2026-05-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
199
65.51
US$13,036 		199 65.51 US$13,036
2026-05-19 2026-05-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
444
65.51
US$29,085 		444 65.51 US$29,085
2026-03-13 2026-03-13 PrS Proposed sale
4.0
Wilson Mark Andrew

Former Officer

Officer
78,510
72.64
US$5,702,966 		78,510 72.64 US$5,702,966
2026-02-20 2026-02-18 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
180 -0.8%
73.00
US$13,140 		180 -0.8% 73.00 US$13,140
2026-02-20 2026-02-18 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
423 -0.6%
73.00
US$30,879 		423 -0.6% 73.00 US$30,879
2026-02-18 2026-02-18 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
423
73.00
US$30,878 		423 73.00 US$30,878
2026-02-18 2026-02-18 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
180
73.00
US$13,140 		180 73.00 US$13,140
2026-01-22 2026-01-20 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
3,867 -15.3%
35.67
US$137,936 		3,867 -15.3% 35.67 US$137,936
2026-01-20 2026-01-20 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
3,867
35.67
US$137,946 		3,867 35.67 US$137,946
2025-11-25 2025-11-25 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
2,207
58.82
US$129,812 		2,207 58.82 US$129,812
2025-11-25 2025-11-25 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
630
58.82
US$37,056 		630 58.82 US$37,056
2025-11-25 2025-11-25 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
1,157
58.82
US$68,053 		1,157 58.82 US$68,053
2025-11-25 2025-11-25 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
630 -2.8%
54.28
US$34,196 		630 -2.8% 54.28 US$34,196
2025-11-25 2025-11-25 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,207 -3.9%
54.28
US$119,796 		2,207 -3.9% 54.28 US$119,796
2025-11-25 2025-11-25 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
1,157 -5.7%
54.28
US$62,802 		1,157 -5.7% 54.28 US$62,802
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,210 -2.4%
48.18
US$58,298 		1,210 -2.4% 48.18 US$58,298
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,156 -4.1%
47.49
US$102,388 		2,156 -4.1% 47.49 US$102,388
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,200 -2.2%
46.41
US$55,692 		1,200 -2.2% 46.41 US$55,692
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,100 -3.7%
45.16
US$94,836 		2,100 -3.7% 45.16 US$94,836
2025-09-09 2025-09-09 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
6,666
46.69
US$311,205 		6,666 46.69 US$311,205
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,136 -2.0%
39.89
US$45,315 		1,136 -2.0% 39.89 US$45,315
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,226 -3.7%
38.82
US$86,413 		2,226 -3.7% 38.82 US$86,413
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
3,304 -5.3%
37.87
US$125,122 		3,304 -5.3% 37.87 US$125,122
2025-09-05 2025-09-05 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
6,666
38.53
US$256,838 		6,666 38.53 US$256,838
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,134 -1.8%
35.80
US$40,597 		1,134 -1.8% 35.80 US$40,597
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
613 -1.0%
34.40
US$21,087 		613 -1.0% 34.40 US$21,087
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,496 -2.3%
33.54
US$50,176 		1,496 -2.3% 33.54 US$50,176
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,923 -2.8%
32.37
US$62,248 		1,923 -2.8% 32.37 US$62,248
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
307 -1.7%
35.69
US$10,957 		307 -1.7% 35.69 US$10,957
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
189 -1.1%
34.41
US$6,503 		189 -1.1% 34.41 US$6,503
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
432 -2.3%
33.60
US$14,515 		432 -2.3% 33.60 US$14,515
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
793 -4.1%
32.43
US$25,717 		793 -4.1% 32.43 US$25,717
2025-09-04 2025-09-04 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
5,166
33.70
US$174,119 		5,166 33.70 US$174,119
2025-09-04 2025-09-04 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
1,721
33.52
US$57,688 		1,721 33.52 US$57,688
2025-09-04 2025-09-02 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,500 -2.2%
30.16
US$45,240 		1,500 -2.2% 30.16 US$45,240
2025-09-04 2025-09-02 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
485 -2.5%
30.10
US$14,598 		485 -2.5% 30.10 US$14,598
2025-09-02 2025-09-02 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
485
30.10
US$14,600 		485 30.10 US$14,600
2025-09-02 2025-09-02 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
1,500
30.16
US$45,244 		1,500 30.16 US$45,244
2025-08-21 2025-08-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
725 -3.6%
26.59
US$19,278 		725 -3.6% 26.59 US$19,278
2025-08-21 2025-08-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
676 -3.2%
26.59
US$17,975 		676 -3.2% 26.59 US$17,975
2025-08-21 2025-08-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,573 -2.2%
26.59
US$41,826 		1,573 -2.2% 26.59 US$41,826
2025-08-19 2025-08-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
1,573
26.59
US$41,826 		1,573 26.59 US$41,826
2025-08-19 2025-08-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
676
26.59
US$17,975 		676 26.59 US$17,975
2025-08-19 2025-08-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
725
26.59
US$19,278 		725 26.59 US$19,278
2025-05-21 2025-05-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
10,712 -3.4%
0.67
US$7,177 		10,712 -3.4% 0.67 US$7,177
2025-05-21 2025-05-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
23,208 -2.1%
0.67
US$15,549 		23,208 -2.1% 0.67 US$15,549
2025-05-21 2025-05-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
9,996 -3.1%
0.67
US$6,697 		9,996 -3.1% 0.67 US$6,697
2025-05-19 2025-05-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
10,712
0.67
US$7,191 		10,712 0.67 US$7,191
2025-05-19 2025-05-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
9,996
0.67
US$6,710 		9,996 0.67 US$6,710
2025-05-19 2025-05-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
23,208
0.67
US$15,580 		23,208 0.67 US$15,580
2025-02-21 2025-02-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
11,040 -3.3%
1.01
US$11,150 		11,040 -3.3% 1.01 US$11,150
2025-02-21 2025-02-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
10,300 -3.2%
1.01
US$10,403 		10,300 -3.2% 1.01 US$10,403
2025-02-21 2025-02-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
23,774 -2.1%
1.01
US$24,012 		23,774 -2.1% 1.01 US$24,012
2025-02-19 2025-02-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
11,040
1.01
US$11,137 		11,040 1.01 US$11,137
2025-02-19 2025-02-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
23,774
1.01
US$23,983 		23,774 1.01 US$23,983
2025-02-19 2025-02-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
10,300
1.01
US$10,391 		10,300 1.01 US$10,391
2024-12-26 2024-12-24 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
16,560
0.89
US$14,801 		16,560 0.89 US$14,801
2024-12-26 2024-12-24 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
16,560 -4.7%
0.89
US$14,738 		16,560 -4.7% 0.89 US$14,738
Explore more

More insider trading research around Nektar Therapeutics

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America